| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 19 | 1 | 2002 | 2019 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.100 | None | 0.833 | 18 | 0 | 2000 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.100 | None | 0.889 | 18 | 2 | 2006 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 2007 | 2019 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1998 | 2017 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 1.000 | 17 | 6 | 1999 | 2018 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 0.938 | 16 | 3 | 2009 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.100 | None | 0.933 | 15 | 4 | 2005 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.100 | None | 0.786 | 14 | 0 | 2004 | 2019 | ||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2010 | 2020 | |||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1994 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0.846 | 13 | 2 | 2000 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 1.000 | 13 | 1 | 1998 | 2017 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2010 | 2019 | |||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 12 | 1 | 2000 | 2019 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
disease | 0.100 | None | 0.833 | 12 | 2 | 2011 | 2020 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
disease | 0.100 | None | 0.917 | 12 | 2 | 2001 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2004 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2008 | 2019 | ||||||||
|
cell adhesion molecule 1 | 0.491 | 0.769 | 0.66 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2004 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 1.000 | 11 | 2 | 2004 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.727 | 11 | 2 | 2005 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 2005 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.100 | None | 1.000 | 10 | 3 | 2007 | 2018 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2008 | 2020 |